# OnCo record paper-patil-mebendazole-glioma-phase-1-cancer-med-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-patil-mebendazole-glioma-phase-1-cancer-med-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-patil-mebendazole-glioma-phase-1-cancer-med-2020" ;
  schema:name "Reverse swing-M, phase 1 study of repurposing mebendazole in recurrent high-grade glioma"@en ;
  schema:description "An Indian phase 1 trial gave a worm medicine to 11 people with recurrent glioblastoma alongside chemotherapy or re-irradiation, found the dose they could tolerate, and saw anaemia and nausea as the most common side effects."@en ;
  schema:url <https://onco.cc/key-papers/paper-patil-mebendazole-glioma-phase-1-cancer-med-2020/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1002/cam4.3094>, <https://pubmed.ncbi.nlm.nih.gov/32400117/> ;
  schema:sameAs <https://doi.org/10.1002/cam4.3094> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Patil VM, Bhelekar A, Menon N, et al." ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:technologies <https://onco.cc/technologies/drug-repurposing/> ;
  onco:drugs <https://onco.cc/drugs/mebendazole/>, <https://onco.cc/drugs/temozolomide/>, <https://onco.cc/drugs/lomustine/> ;
  onco:terms <https://onco.cc/terms/rp2d/>, <https://onco.cc/terms/dose-escalation-design/> ;
  onco:journals <https://onco.cc/journals/cancer-medicine/> .